Study authors said routine surveillance is needed to monitor for the emergence of drug resistance to safeguard the effectiveness of TPOXX, one of the few treatments approved for treatment of mpox.

CHICAGO (Reuters) - U.S. health officials have identified a cluster of cases caused by an mpox variant that are resistant to Siga Technologies' antiviral tecovirimat, branded as TPOXX, in five U.S ...

CHICAGO (Reuters) - U.S. health officials have identified a cluster of cases caused by an mpox variant that are resistant to Siga Technologies' antiviral tecovirimat, branded as TPOXX, in five U.S.

SAN FRANCISCO, CA / ACCESSWIRE / October 9, 2024 / Biopharmaceutical company SIGA Technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead ...

The Washington Post’s essential guide to health policy news Good morning, and happy Friday! Recent developments in Alzheimer’s disease treatment, including the approval of two new drugs, are ...

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness.